Association between Functional PSMD10 Rs111638916 Variant Regulated by MiR-505 and Gastric Cancer Risk in a Chinese Population

Cellular Physiology and Biochemistry

Volumn 37, Issue 3, 2020, Pages 1010-1017

  Liu, Yong ^a   Xu, Jianzhong ^a   Jiang, Min ^a   Ni, Lingna ^a   Chen, Yun ^b   Ling, Yang ^a  

^a China   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

3 UTR; Genotype; Metastasis; MiR 505; Tumor growth

Indexed keywords

ADENINE; GUANINE; MICRORNA; MICRORNA 505; ONCOPROTEIN; PSMD10 PROTEIN; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; MIRN505 MICRORNA, HUMAN; PROTEASOME; PSMD10 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ADULT; ALCOHOL CONSUMPTION; ALLELE; ARTICLE; CANCER PATIENT; CANCER RISK; CANCER SIZE; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; FEMALE; GENE CONTROL; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC TRANSFECTION; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; LUCIFERASE ASSAY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; METASTASIS; MIDDLE AGED; POPULATION BASED CASE CONTROL STUDY; POPULATION GENETICS; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSMD10 GENE; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; STOMACH CANCER; TUMOR SUPPRESSOR GENE; UPREGULATION; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGY; CHINA; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; PATHOLOGY; PROCEDURES; STOMACH TUMOR; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CELL LINE, TUMOR; CHINA; COMPUTATIONAL BIOLOGY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTO-ONCOGENE PROTEINS; STOMACH NEOPLASMS;

EID: 84942258889     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000430227     Document Type: Article

References (32)

1. Chen L, Jiang M, Yuan W, Tang H: Prognostic value of mir-93 overexpression in resectable gastric adenocarcinomas. Acta Gastroenterol Belg 2012;75:22-27.
2. Arita T, Ichikawa D, Konishi H, Komatsu S, Shiozaki A, Shoda K, Kawaguchi T, Hirajima S, Nagata H, Kubota T, Fujiwara H, Okamoto K, Otsuji E: Circulating long non-coding rnas in plasma of patients with gastric cancer. Anticancer Res 2013;33:3185-3193.
3. Guo X, Jing C, Li L, Zhang L, Shi Y, Wang J, Liu J, Li C: Down-regulation of vezt gene expression in human gastric cancer involves promoter methylation and mir-43c. Biochem Biophys Res Commun 2011;404:622-627.
4. McGee DJ, Mobley HL: Pathogenesis of helicobacter pylori infection. Curr Opin Gastroenterol 2000;16:24-31.
5. Liu Z, Zhang J, Gao Y, Pei L, Zhou J, Gu L, Zhang L, Zhu B, Hattori N, Ji J, Yuasa Y, Kim W, Ushijima T, Shi H, Deng D: Large-scale characterization of DNA methylation changes in human gastric carcinomas with and without metastasis. Clin Cancer Res 2014;20:4598-4612.
6. Tsai KW, Wu CW, Hu LY, Li SC, Liao YL, Lai CH, Kao HW, Fang WL, Huang KH, Chan WC, Lin WC: Epigenetic regulation of mir-34b and mir-129 expression in gastric cancer. Int J Cancer 2011;129:2600-2610.
7. Lin LL, Huang HC, Juan HF: Revealing the molecular mechanism of gastric cancer marker annexin a4 in cancer cell proliferation using exon arrays. PLoS One 2012;7:e44615.
8. Hoepler W, Hammer K, Hammer J: Gastric phenotype in children with helicobacter pylori infection undergoing upper endoscopy. Scand J Gastroenterol 2011;46:293-298.
9. Zhu Y, Xia Y, Niu H, Chen Y: Mir-16 induced the suppression of cell apoptosis while promote proliferation in esophageal squamous cell carcinoma. Cell Physiol Biochem 2014;33:1340-1348.
10. Zhang JX, Song W, Chen ZH, Wei JH, Liao YJ, Lei J, Hu M, Chen GZ, Liao B, Lu J, Zhao HW, Chen W, He YL, Wang HY, Xie D, Luo JH: Prognostic and predictive value of a microrna signature in stage ii colon cancer: A microrna expression analysis. Lancet Oncol 2013;14:1295-1306.
11. Ying SY, Chang DC, Lin SL: The microrna. Methods Mol Biol 2013;936:1-19.
12. Zhang J, Yu H, Zhang Y, Zhang X, Zheng G, Gao Y, Wang C, Zhou L: A functional tnfaip2 3'-utr rs8126 genetic polymorphism contributes to risk of esophageal squamous cell carcinoma. PLoS One 2014;9:e109318.
13. Wang K, Xu L, Pan L, Xu K, Li G: The functional brca1 rs799917 genetic polymorphism is associated with gastric cancer risk in a chinese han population. Tumour Biol 2015;36:393-397.
14. Wang Y, Zhou L, Chen J, Li J, He L, Wu P, Wang M, Tong N, Zhang Z, Fang Y: Association of the 3'utr foxo3a polymorphism rs4946936 with an increased risk of childhood acute lymphoblastic leukemia in a chinese population. Cell Physiol Biochem 2014;34:325-332.
15. Padmanabhan B, Adachi N, Kataoka K, Horikoshi M: Crystal structure of the homolog of the oncoprotein gankyrin, an interactor of rb and cdk4/6. J Biol Chem 2004;279:1546-1552.
16. Su B, Luo T, Zhu J, Fu J, Zhao X, Chen L, Zhang H, Ren Y, Yu L, Yang X, Wu M, Feng G, Li S, Chen Y, Wang H: Interleukin-1beta/iinterleukin-1 receptor-Associated kinase 1 inflammatory signaling contributes to persistent gankyrin activation during hepatocarcinogenesis. Hepatology 2015;61:585-597.
17. Hwang JA, Yang HM, Hong DP, Joo SY, Choi YL, Park JH, Lazar AJ, Pollock RE, Lev D, Kim SJ: Gankyrin is a predictive and oncogenic factor in well-differentiated and dedifferentiated liposarcoma. Oncotarget 2014;5:9065-9078.
18. Zheng T, Hong X, Wang J, Pei T, Liang Y, Yin D, Song R, Song X, Lu Z, Qi S, Liu J, Sun B, Xie C, Pan S, Li Y, Luo X, Li S, Fang X, Bhatta N, Jiang H, Liu L: Gankyrin promotes tumor growth and metastasis through activation of il-6/stat3 signaling in human cholangiocarcinoma. Hepatology 2014;59:935-946.
19. Bai Z, Tai Y, Li W, Zhen C, Gu W, Jian Z, Wang Q, Lin JE, Zhao Q, Gong W, Liang B, Wang C, Zhou T: Gankyrin activates il-8 to promote hepatic metastasis of colorectal cancer. Cancer Res 2013;73:4548-4558.
20. Iakova P, Timchenko L, Timchenko NA: Intracellular signaling and hepatocellular carcinoma. Semin Cancer Biol 2011;21:28-34.
21. Lozano G, Zambetti GP: Gankyrin: An intriguing name for a novel regulator of p53 and rb. Cancer cell 2005;8:3-4.
22. Lim IK: Spectrum of molecular changes during hepatocarcinogenesis induced by den and other chemicals in fischer 344 male rats. Mech Ageing Dev 2002;123:1665-1680.
23. Nanaware PP, Ramteke MP, Somavarapu AK, Venkatraman P: Discovery of multiple interacting partners of gankyrin, a proteasomal chaperone and an oncoprotein-evidence for a common hot spot site at the interface and its functional relevance. Proteins 2014;82:1283-1300.
24. Kim KH, Lim HJ, Kim YJ, Kim SW, Kim YS, Tian C, Park K, Park TJ, Choung YH: The oncoprotein, gankyrin, is up-regulated in middle ear cholesteatoma. Acta Otolaryngol 2014;134:238-243.
25. Chen X, Zhang M, Liu LX: The overexpression of multidrug resistance-Associated proteins and gankyrin contribute to arsenic trioxide resistance in liver and gastric cancer cells. Oncol Rep 2009;22:73-80.
26. Kim YH, Kim JH, Choi YW, Lim SK, Yim H, Kang SY, Chung YS, Lee GY, Park TJ: Gankyrin is frequently overexpressed in breast cancer and is associated with erbb2 expression. Exp Mol Pathol 2013;94:360-365.
27. Gao L, Xie H, Dong L, Zou J, Fu J, Gao X, Ou L, Xiang S, Song H: Gankyrin is essential for hypoxia enhanced metastatic potential in breast cancer cells. Mol Med Rep 2014;9:1032-1036.
28. Mine H, Sakurai T, Kashida H, Matsui S, Nishida N, Nagai T, Hagiwara S, Watanabe T, Kudo M: Association of gankyrin and stemness factor expression in human colorectal cancer. Dig Dis Sci 2013;58:2337-2344.
29. Valastyan S, Reinhardt F, Benaich N, Calogrias D, Szasz AM, Wang ZC, Brock JE, Richardson AL, Weinberg RA: A pleiotropically acting microrna, mir-31, inhibits breast cancer metastasis. Cell 2009;137:1032-1046.
30. Hyun S, Lee JH, Jin H, Nam J, Namkoong B, Lee G, Chung J, Kim VN: Conserved microrna mir-8/mir-200 and its target ush/fog2 control growth by regulating pi3k. Cell 2009;139:1096-1108.
31. Wang K, Diskin SJ, Zhang H, Attiyeh EF, Winter C, Hou C, Schnepp RW, Diamond M, Bosse K, Mayes PA, Glessner J, Kim C, Frackelton E, Garris M, Wang Q, Glaberson W, Chiavacci R, Nguyen L, Jagannathan J, Saeki N, Sasaki H, Grant SF, Iolascon A, Mosse YP, Cole KA, Li H, Devoto M, McGrady PW, London WB, Capasso M, Rahman N, Hakonarson H, Maris JM: Integrative genomics identifies lmo1 as a neuroblastoma oncogene. Nature 2011;469:216-220.
32. Bartel DP: Micrornas: Genomics, biogenesis, mechanism, and function. Cell 2004;116:281-297.